Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1ouy | 094 | Mitogen-activated protein kinase 14 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 1.000 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.579 | |
1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.552 | |
3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.550 | |
3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.545 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.544 | |
1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.542 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.531 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.528 | |
3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.525 | |
3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.525 | |
3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.523 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.520 | |
4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.519 | |
2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.517 | |
4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.508 | |
1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.507 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.507 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.507 | |
3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.503 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.502 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.498 | |
4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.498 | |
3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.497 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.495 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.494 | |
3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.493 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.493 | |
3iw5 | DF3 | Mitogen-activated protein kinase 14 | / | 0.492 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.492 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.491 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.491 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.490 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.490 | |
3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.489 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.488 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.488 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.485 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.485 | |
1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.481 | |
3iw6 | PP0 | Mitogen-activated protein kinase 14 | / | 0.481 | |
3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.480 | |
3oc1 | BMU | Mitogen-activated protein kinase 14 | / | 0.480 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.479 | |
1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.478 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.478 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.477 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.477 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
3fml | FML | Mitogen-activated protein kinase 14 | / | 0.476 | |
3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.476 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.474 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.474 | |
4j1t | NAD | NAD/NADP transhydrogenase alpha subunit 1 | / | 0.474 | |
2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.471 | |
2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.471 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.471 | |
3fsf | FSS | Mitogen-activated protein kinase 14 | / | 0.471 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.471 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.467 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.467 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.466 | |
1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.465 | |
2yix | YIX | Mitogen-activated protein kinase 14 | / | 0.465 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.465 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.464 | |
3wrl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.464 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.463 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.463 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.463 | |
4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.463 | |
3bv2 | P38 | Mitogen-activated protein kinase 14 | / | 0.462 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.462 | |
1bl7 | SB4 | Mitogen-activated protein kinase 14 | / | 0.461 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.461 | |
3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.460 | |
3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.458 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.457 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.456 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.456 | |
3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.455 | |
3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.455 | |
3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.454 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.454 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.453 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.453 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.453 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.452 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.451 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
1kzj | CB3 | Thymidylate synthase | / | 0.450 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.450 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.450 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.447 | |
2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.447 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.446 | |
2znp | K55 | Peroxisome proliferator-activated receptor delta | / | 0.446 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.446 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.446 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.446 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.446 | |
1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.445 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
3wrh | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.443 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.443 | |
4l4a | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1yrc | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.442 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.442 | |
4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.442 | |
2eau | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.441 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4c9o | CAM | Cytochrome P450 | / | 0.441 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.441 | |
4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.441 | |
2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.440 | |
2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.440 |